Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRACE: VH3810109 + Cabotegravir in Virologically Suppressed Adults Living With HIV
NCT05996471Phase 2Active, not recruiting
- Sponsor
- ViiV Healthcare
- Start
- Aug 2023
- Primary completion
- May 2026
- Countries
- 2
01
Overview
A Phase 2 trial of VH3810109 in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Aug 2023; status: active, not recruiting.
02
Drugs
VH3810109
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05996471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05996471.